Vitrakvi 71777-0392
Generic: Larotrectinib
Product NDC
71777-0392- Manufacturer
- Loxo Oncology, Inc.
- Dosage Form
- Solution
- Route
- Oral
- Product Type
- Human Prescription Drug
- Marketing Start
- November 26, 2018
- Listing Expires
- December 31, 2026
- Application
- NDA211710
Need to source Vitrakvi? Find it on a pharmacy-to-pharmacy marketplace at better prices.
✓ DSCSA Compliant. ✓ Verified Pharmacies Only.P2P pharmacy marketplace.
Active Ingredients
| Ingredient | Strength |
|---|---|
| Larotrectinib | 20 mg/mL |
Drug Class
Kinase Inhibitor [EPC]Kinase Inhibitor [EPC]Tropomyosin Receptor Kinases Inhibitors [MoA]
Packaging Options(1)
100 mL in 1 BOTTLE (71777-392-01)